Financial, market and economic news

COVID Vaccine: Bharat Biotech’s COVAXIN expected to be at least 60% effective, roll-out likely by mid-2021

Read More

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. AcceptRead More

Privacy & Cookies Policy